Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts DFTX Hot Sheet
Join SI Premium – FREE
Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Citius Oncology presents LYMPHIR quality of life data at Berlin congress
- SMX -- Good Intentions Don't Count; Measured Plastic Does
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
